TAKANASHI KEN purchased 789.3% of their position (22.05M shares) of SATSUMA PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $20.07M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/8/2023ACC: 0000899243-23-014896
Director10% Owner
Since Sep 2019
+21.99M
Net shares
Net buyer
$20.07M
Total acquired
1
Open market trades
1B · 0S
4
Total transactions
22.05M acquired · 60K disposed
Non-Derivative Transactions1
Common Stock, $0.0001 par value
Indirect
Shares
+22.05M
Price / share
$0.91
Trade value
$20.07M
% of position
789.3%
6/6/2023
2.79M→24.85M
Total
Net shares
+22.05M
Net value
$20.07M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value Indirect | 6/6/2023 | P · Purchase | +22.05M | $0.91 | $20.07M | 789.3% | 2.79M | 24.85M |
| Total | +22.05M | $20.07M | ||||||
Derivative Transactions3
Stock Option (right to buy)
Direct
Converts to
Common Stock
10K shares
Shares
−10K
Strike price
26.99
Held after
0.00
Exercisable
—
6/8/2023
Stock Option (right to buy)
Direct
Converts to
Common Stock
20K shares
Shares
−20K
Strike price
4.60
Held after
0.00
Exercisable
—
6/8/2023
Stock Option (right to buy)
Direct
Converts to
Common Stock
30K shares
Shares
−30K
Strike price
3.46
Held after
0.00
Exercisable
—
6/8/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock10K shares | 6/8/2023 | D · Disposition | −10K | 26.99 | — | 0.00 |
| Stock Option (right to buy) Direct | Common Stock20K shares | 6/8/2023 | D · Disposition | −20K | 4.60 | — | 0.00 |
| Stock Option (right to buy) Direct | Common Stock30K shares | 6/8/2023 | D · Disposition | −30K | 3.46 | — | 0.00 |